GlobeNewsWire
28 Jul 2026, 21:30 UTC · 14w ago
Impact · against what's priced in
Health Catalyst is expected to see a positive impact from the $147 million divestiture of its Vitalware business, which provides a significant liquidity boost. The upcoming earnings announcement is a standard event and not a fundamental driver.
No priced-in read yet
What the story claims
2 claims · scored −1 bearish … +1 bullish
Health Catalyst has signed a definitive agreement to divest its Vitalware mid-revenue cycle business to Med-Metrix for $147 million.
More positive than 92% of claims this week
Health Catalyst will announce its second quarter 2026 operating results on Thursday, August 6, 2026, after market close.
Continue reading
5 related stories
The agreement to sell the Vitalware mid-revenue cycle business for $147 million provides a cash infusion that improves the company's balance sheet and strategic focus.
Read from the article alone
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 40% of claims this week
Which stocks this story touches
More positive than 57% of ticker scores this week
The company is announcing upcoming earnings and successfully divesting a business unit for $147 million.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
24/7 Wall Street
38m ago
−29.9%
Price is moving against the score
$1.50 vs $2.14 close before publication (Jul 28) · not market-adjusted
HCAT chart →
